PIRAMALFINNSEPiramal Finance LimitedHighNeutral
Announced Tue, 26 May · 19:23 IST

Piramal Finance Limited has informed the Exchange about receipt of Order from Honourable NCLAT, Delhi Bench, allowing dispensation from convening equity shareholders meeting in relation to the Scheme of Amalgamation amongst the Company, Piramal Corporate Tower Private Limited, Piramal Agastya Offices Private Limited and DHFL Investments Limited.

Nclt Resolution ApprovedRegulatory & Legal View source PDF

PIRAMALFIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹1952.00
prior close
₹1957.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6+0.5+0.3-0.0-0.8-0.6-2.0-1.0+0.9+0.8+2.7+9.8+4.5
Up moveDown movePending
AI summary

Piramal Finance Limited received an order from NCLAT Delhi allowing the company to skip holding an equity shareholders meeting for its proposed amalgamation with three wholly-owned subsidiaries: Piramal Corporate Tower Private Limited, Piramal Agastya Offices Private Limited, and DHFL Investments Limited. The company had appealed after NCLT Mumbai initially directed that such a meeting be convened. NCLAT agreed with Piramal's argument that since the transferor companies are wholly-owned subsidiaries, no new shares are being issued, and there is no change in the capital structure or shareholder rights, a meeting was unnecessary. The company's pre-merger net worth stands at ₹23,710.54 crore and post-merger net worth at ₹23,449.63 crore, demonstrating robust financial health. NCLAT however directed that notices to equity shareholders also be sent, similar to the requirement for secured and unsecured creditors.

Likely market impact

This is a positive procedural development for the amalgamation. By dispensing with the shareholders meeting, the process moves forward more efficiently without affecting shareholder rights since no capital restructuring is involved. The stock is listed on BSE (Scrip: 544597) and NSE (Symbol: PIRAMALFIN).